Acumen Pharmaceuticals, Inc.
Ticker: ABOS
| Insider | Title |
|---|---|
| Amy Schacterle | Chief Regulatory Officer |
| Capital Global Venture Fund Ii, L.p. Sands | 10% or greater ownership |
| Capital Healthcare Fund Lp Ra | Director, 10% or greater ownership |
| Capital Life Sciences Pulse Fund, Llc Sands | 10% or greater ownership |
| Capital Management, L.p. Ra | Director, 10% or greater ownership |
| Capital Nexus Fund Ii, L.p. Ra | Director, 10% or greater ownership |
| Capital Ventures Discovery Fund Iii, L.p. Sands | 10% or greater ownership |
| Daniel Joseph Oconnell | President and CEO, Director |
| Derek M Meisner | Chief Legal Officer Corp Sec |
| Derrell Porter | Director |
| Eric Siemers | Chief Medical Officer |
| Frank M. Sands | 10% or greater ownership |
| James J. Doherty | President and CDO |
| Jeffrey L. Ives | Director |
| Jeffrey Sevigny | Director |
| John A Iii Stalfort | Director |
| Kimberlee C Drapkin | Director |
| Laura Stoppel | Director |
| Matt Zuga | CFO Chief Business Officer |
| Nathan B Fountain | Director |
| Paul B Manning | 10% or greater ownership |
| Peter Kolchinsky | Director, 10% or greater ownership |
| Rajeev M. Shah | Director, 10% or greater ownership |
| Robert D. Hardie | 10% or greater ownership |
| Russell Barton | Chief Operating Officer |